London-based GHO Capital invests in Boston's ClearView Healthcare Partners

London-based GHO Capital invests in Boston's ClearView Healthcare Partners
Brands
Lifesciences shutterstock 181678880

Global Healthcare Opportunities (GHO) Capital Capital Partners LLP, a London-based healthcare specialist investor and the founding partners of ClearView Healthcare Partners recently, announced a majority recapitalization of ClearView Healthcare Partners, a life sciences strategic consulting firm supporting pharmaceutical and biotechnology sponsors, according to a press release from GHO Capital.

Boston-based ClearView is led by its founders Rich Mynahan, Steve Chao and Kevin Richard.

"We are excited to be working with GHO given their extensive healthcare expertise and experience in geographic expansion across Europe and the US," the  ClearView founders stated in the press release, "We believe GHO is the right partner for ClearView as we look to new markets and drive the expansion and growth of the company to its next level. We thank RLH Equity Partners for their support in contributing to ClearView’s position as a market leader in the life sciences consulting sector."

ClearView is known for integrating its clinical knowledge with business insights to provide practical suggestions to its clients in order to help them achieve their growth and innovation goals.

"We are delighted to have the opportunity to partner with the ClearView team," GHO Capital partners stated in the press release, "Operating within a highly fragmented market, ClearView is a best-in-class consultancy within the life sciences space.

GHO  reportedly acquired a majority stake in ClearView from RLH Equity Partners for an undisclosed amount with the firm's founding partners and leadership maintaining a significant ownership holding.

"We believe GHO, with its strong sector expertise, is uniquely positioned to build on ClearView’s strong track record and reputation," the GHO partners stated, "We look forward to supporting the business in driving international expansion and building out its domain expertise to deliver strategically critical insights to its Biopharma customer base.”

Additionally, the investment follows the announcement of GHO Cash III in July 2021, which will include approximately $2,376,700,000 in available capital, additional team members and the establishment of a U.S. office in North Carolina's Research Triangle Park to assist GHO's network of North American businesses.

GHO received legal advice from Ropes & Gray; commercial advice from Marwood; financial, tax and debt advice from Deloitte LLP; ESG advice from Bridgehouse Advisors; and insurance advice from Hays.

Clearsight Advisors and Houlihan Lokey LLP served as co-strategic advisers to ClearView, while Winston & Strawn and Foley Hoag LLP served as legal counsel and RSM US LLP served as financial and tax adviser.